RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DI LORENZO G
Collezione AOU San Luigi di Orbassano

Items : 8

Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group. in Current neuropharmacology / Curr Neuropharmacol. 2025;23(5):e1570159X337670. doi: 10.2174/011570159X337670241029062524.

2025
AOU San Luigi di Orbassano

Rosso G; d'Andrea G; Barlati S; Di Nicola M; Andriola I; Marcatili M; Martiadis V; Olivola M; Di Mauro S; Di Salvo G; De Fazio P; Clerici M; Dell'Osso BM; Vita A; Di Lorenzo G; Pettorruso M; Martinotti G; Maina G;

Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2023 Oct;21(5):574-583. doi: 10.1016/j.clgc.2023.05.017. Epub 2023 May 27.

2023
AOU San Luigi di Orbassano

Ferro M; Crocetto F; Tataru S; Barone B; Dolce P; Lucarelli G; Sonpavde G; Musi G; Antonelli A; Veccia A; Terracciano D; Busetto GM; Del Giudice F; Marchioni M; Schips L; Porpiglia F; Fiori C; Carrieri G; Lasorsa F; Verde A; Scafuri L; Buonerba C; Di Lorenzo G;

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis. in European urology / Eur Urol. 2022 Apr;81(4):414-425. doi: 10.1016/j.eururo.2022.01.028. Epub 2022 Jan 31.

2022
AOU San Luigi di Orbassano

Wu Z; Chen Q; Qu L; Li M; Wang L; Mir MC; Carbonara U; Pandolfo SD; Black PC; Paul AK; Di Lorenzo G; Porpiglia F; Mari A; Necchi A; Rouprêt M; Psutka SP; Autorino R;

A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy. in Future oncology (London, England) / Future Oncol. 2021 Oct;17(30):3987-3994. doi: 10.2217/fon-2020-1298. Epub 2021 Jul 19.

2021
AOU San Luigi di Orbassano

Ferro M; Lucarelli G; de Cobelli O; Dolce P; Terracciano D; Musi G; Porreca A; Busetto GM; Del Giudice F; Soria F; Gontero P; Cantiello F; Damiano R; Crocerossa F; Abu Farhan AR; Autorino R; Vartolomei MD; Marchioni M; Mari A; Minervini A; Longo N; Celentano G; Chiancone F; Perdonà S; Del Prete P; Ditonno P; Battaglia M; Zamboni S; Antonelli A; et alii...

Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. in JAMA network open / JAMA Netw Open. 2020 Oct 1;3(10):e2021692. doi: 10.1001/jamanetworkopen.2020.21692.

2020
AOU San Luigi di Orbassano

Schmid S; Omlin A; Higano C; Sweeney C; Martinez Chanza N; Mehra N; Kuppen MCP; Beltran H; Conteduca V; Vargas Pivato de Almeida D; Cotait Maluf F; Oh WK; Tsao CK; Sartor O; Ledet E; Di Lorenzo G; Yip SM; Chi KN; Bianchini D; De Giorgi U; Hansen AR; Beer TM; Lavaud P; Morales-Barrera R; Tucci M; Castro E; Karalis K; Bergman AM; Le ML; et alii...

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18.

2016
AOU San Luigi di Orbassano

Veccia A; Caffo O; De Giorgi U; Di Lorenzo G; Ortega C; Scognamiglio F; Aieta M; Facchini G; Mansueto G; Mattioli R; Procopio G; Zagonel V; D'Angelo A; Spizzo G; Bortolus R; Donini M; Lo Re G; Massari F; Vicario G; Zucali PA; Alesini D; Bonetti A; Mucciarini C; Nicodemo M; Berruti A; Fratino L; Lodde M; Messina C; Perin A; et alii...

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger. in Urologic oncology / Urol Oncol. 2015 Jun;33(6):265.e15-21. doi: 10.1016/j.urolonc.2015.02.016. Epub 2015 Apr 20.

2015
AOU San Luigi di Orbassano

Caffo O; Ortega C; Di Lorenzo G; Sava T; De Giorgi U; Cavaliere C; Macrini S; Spizzo G; Aieta M; Messina C; Tucci M; Lodde M; Mansueto G; Zucali PA; Alesini D; D'Angelo A; Massari F; Morelli F; Procopio G; Ratta R; Fratino L; Lo Re G; Pegoraro MC; Zustovich F; Vicario G; Ruatta F; Federico P; La Russa F; Burgio SL; et alii...